CHCS Report Maps How Texas Medicaid Could Cover the National Diabetes Prevention Program — Diabetes Care Could Cost Texas Medicaid $8.1B a Year
A June 2026 Center for Health Care Strategies report, funded by the Episcopal Health Foundation, examines options for Texas Medicaid to cover the CDC's National Diabetes Prevention Program. The stakes: more than seven million Texas adults have prediabetes, 13.2% have diagnosed diabetes, and diabetes care could cost Texas Medicaid $8.1 billion annually — nearly 21 percent of total Medicaid spending.
The report maps coverage pathways through State Plan Amendments, Section 1115 demonstrations, and Medicaid managed-care pilots. Texas Medicaid does not currently cover the National DPP; whether and how a future benefit would reach health centers is an open design question — no current reimbursement pathway exists, so health centers should treat this as a policy-watch item, not a revenue line.
Source packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
This story will move — get the follow-up
The weekly FQHC Intel Brief traces every claim to a primary source, like the one above. Free.
You are signing up for the newsletter you choose, a short welcome sequence, occasional product updates, and one-click unsubscribe. We do not sell your email. Privacy Policy · Do Not Sell/Share
FQHC Talent. (2026, June 30). CHCS Report Maps How Texas Medicaid Could Cover the National Diabetes Prevention Program — Diabetes Care Could Cost Texas Medicaid $8.1B a Year. Primary source: Center for Health Care Strategies (funded by Episcopal Health Foundation). Retrieved July 21, 2026, from https://www.fqhctalent.com/intel/tx-chcs-national-dpp-medicaid-coverage-report-june-2026
More in Legislation
Jul 16
CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14
Jul 1
8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge
Jun 30
AHA Files En Banc Review Petition After 4th Circuit Blocks WV 340B Contract Pharmacy Law — Decision Expected Mid-May
Jun 29
25 States + DC Sue HHS/CMS Over the Work-Requirement Rule's Narrowed 'Medically Frail' Exemption — the First Direct Legal Challenge to the IFR